The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, requires a complex several-stage synthetic process. Preliminary routes focused on amino acid chain portion coupling, utilizing https://mathejayj056500.blogs-service.com/71805233/production-and-research-implementations-of-retatrutide